Trials
Search / Trial NCT06416631

Artificial Intelligence Versus Maunal Planning in Robot Assisted Spinal Surgery

Launched by BEIJING JISHUITAN HOSPITAL · May 12, 2024

Trial Information

Current as of February 12, 2025

Not yet recruiting

Keywords

ClinConnect Summary

Study design:

multicenter, non-inferiority, open-label, randomized controlled trial in patients undergoing robotic spinal surgery.

Monitoring:

Monitoring of patient's safety and effectiveness data is performed by a designated independent Data Safety and Monitoring Board (DSMB). The DSMB watches over the ethics of conducting the study in accordance with the Declaration of Helsinki.

Sample Size Calculation:

Group size calculation is focused on demonstrating non-inferiority. Assuming that the percentage of clinically acceptable screws would be 90% in the artificial intelligence planning g...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Admission to one of the participating centers;
  • Need for and start of robotic spinal surgery
  • Patients had complete medical records and imaging data;
  • Exclusion Criteria:
  • Age less than 18 years;
  • Patients with severe comorbidities;
  • Patients diagnosed with tumor diseases;
  • Inability to carry out the intervention (mental of physical conditions that limited participation);
  • Patients with morbid obesity (body mass index \> 40);
  • Missing medical records and imaging data;
  • Patients with suspected or confirmed pregnancy;
  • Patients participating in another RCT with the same clinical endpoint, or interventions possibly compromising the primary outcome;
  • No informed consent.

About Beijing Jishuitan Hospital

Beijing Jishuitan Hospital is a renowned medical institution specializing in orthopedic and trauma care, with a strong emphasis on research and clinical innovation. As a leading clinical trial sponsor, the hospital is dedicated to advancing medical knowledge and improving patient outcomes through rigorous scientific studies. With a team of experienced researchers and healthcare professionals, Beijing Jishuitan Hospital collaborates with various stakeholders to conduct high-quality clinical trials that adhere to ethical standards and regulatory requirements. Its commitment to excellence in patient care and research positions the hospital as a pivotal player in the field of medical advancements.

Locations

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0